# FDA Inspection 1247725 - Jiangxi Tianxin Pharmaceutical Co., Ltd. - July 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/jiangxi-tianxin-pharmaceutical-co-ltd/cea8954f-cee4-4495-9f6b-491a8d4c7a20
Source feed: FDA_Inspections

> FDA Inspection 1247725 for Jiangxi Tianxin Pharmaceutical Co., Ltd. on July 19, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1247725
- Company Name: Jiangxi Tianxin Pharmaceutical Co., Ltd.
- Inspection Date: 2024-07-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 921562 - 2015-04-03](https://www.keypedia.com/records/fda_inspections/jiangxi-tianxin-pharmaceutical-co-ltd/a27c91ce-26e6-4ec7-8d75-53faf921e04f)
- [FDA Inspection 808855 - 2012-11-01](https://www.keypedia.com/records/fda_inspections/jiangxi-tianxin-pharmaceutical-co-ltd/90bfd318-acbe-4b08-91cb-5d9acb670fac)
- [FDA Inspection 808855 - 2012-11-01](https://www.keypedia.com/records/fda_inspections/jiangxi-tianxin-pharmaceutical-co-ltd/e8220106-c630-47c9-a33e-6aed546a2f0a)

Company: https://www.keypedia.com/companies/jiangxi-tianxin-pharmaceutical-co-ltd/1c0fef86-efa4-4828-8757-9fc340c7db21

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c